432
Cytek Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
454
FY23:
392
FY24:
396
FY25:
392
(positive)
Change from FY21 to FY25
millions USD
FY21:
31.6
FY22:
65.5
FY23:
102
FY24:
103
FY25:
69.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
463
FY22:
519
FY23:
494
FY24:
500
FY25:
462
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
33.2
FY22:
49.0
FY23:
56.2
FY24:
67.7
FY25:
77.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
24.7
FY22:
44.9
FY23:
45.2
FY24:
36.1
FY25:
42.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
405
FY22:
426
FY23:
393
FY24:
396
FY25:
342
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
463
FY22:
519
FY23:
494
FY24:
500
FY25:
462
All amounts in millions USD